{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:26:07Z","timestamp":1785493567958,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03902-6","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:07:58Z","timestamp":1734520078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chronic kidney disease and adherence improvement program by clinical pharmacist-provided medication therapy management; a quasi-experimental assessment of patients\u2019 self-care perception and practice"],"prefix":"10.1186","volume":"25","author":[{"given":"Ghader","family":"Mohammadnezhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Ehdaivand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrshad","family":"Sebty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behniya","family":"Azadmehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Ziaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Esmaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"5","key":"3902_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.healthpol.2015.02.007","volume":"119","author":"E Mossialos","year":"2015","unstructured":"Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K, et al. From retailers to health care providers: transforming the role of community pharmacists in chronic disease management. Heal Policy (New York). 2015;119(5):628\u201339.","journal-title":"Heal Policy (New York)"},{"issue":"9","key":"3902_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.22159\/ijpps.2017v9i9.19881","volume":"9","author":"JA Thomas","year":"2017","unstructured":"Thomas JA, Snigdha KS, Karanath PM, Swaroop AM, IMPACT OF PATIENT COUNSELLING ON KNOWLEDGE, ATTITUDE, AND PRACTICE OF HYPERTENSIVE PATIENTS IN A TERTIARY CARE HOSPITAL. Int J Pharm Pharm Sci. 2017;9(9):122.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"2","key":"3902_CR3","doi-asserted-by":"publisher","first-page":"e0263412","DOI":"10.1371\/journal.pone.0263412","volume":"17","author":"GS Paneerselvam","year":"2022","unstructured":"Paneerselvam GS, Aftab RA, Sirisinghe RG, Mei Lai PS, Lim SK. Study protocol: effectiveness of patient centered pharmacist care in improving medication adherence, clinical parameters and quality of life among hemodialysis patients. PLoS ONE. 2022;17(2):e0263412.","journal-title":"PLoS ONE"},{"issue":"5","key":"3902_CR4","first-page":"561","volume":"23","author":"JP Vande Griend","year":"2017","unstructured":"Vande Griend JP, Rodgers M, Nuffer W. Effect of an advanced pharmacy practice experience on medication therapy management services in a centralized retail pharmacy program. J Manag Care Spec Pharm. 2017;23(5):561\u20135.","journal-title":"J Manag Care Spec Pharm"},{"key":"3902_CR5","doi-asserted-by":"crossref","unstructured":"Tan R, Cvetkovski B, Kritikos V, Yan K, Price D, Smith P et al. Management of allergic rhinitis in the community pharmacy: identifying the reasons behind medication self-selection. Pharm Pract. 2018;16(3).","DOI":"10.18549\/PharmPract.2018.03.1332"},{"key":"3902_CR6","doi-asserted-by":"crossref","unstructured":"Kim AJ, Lee H, Shin EJ, Cho EJ, Cho YS, Lee H et al. Pharmacist-led collaborative Medication Management for the Elderly with chronic kidney Disease and Polypharmacy. Int J Environ Res Public Health. 2021;18(8).","DOI":"10.3390\/ijerph18084370"},{"issue":"1","key":"3902_CR7","first-page":"18","volume":"15","author":"MJ Barnett","year":"2009","unstructured":"Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, et al. Analysis of pharmacist-provided medication Therapy Management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009;15(1):18\u201331.","journal-title":"J Manag Care Pharm"},{"issue":"3","key":"3902_CR8","first-page":"185","volume":"16","author":"DR De Oliveira","year":"2010","unstructured":"De Oliveira DR, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16(3):185\u201395.","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"3902_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.46542\/pe.2021.211.781788","volume":"21","author":"S Shivaprasad","year":"2021","unstructured":"Shivaprasad S, Mateti UV, Shenoy P, Shastry CS, Dharmagadda S. REVIEW: clinical pharmacists\u2019 scope of knowledge for medication therapy management in chronic kidney disease patients. Pharm Educ. 2021;21(1):781\u20138.","journal-title":"Pharm Educ"},{"issue":"4","key":"3902_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1331\/JAPhA.2013.13003","volume":"53","author":"Rettig","year":"2013","unstructured":"Rettig SM, Wood Y, Hirsch JD. Medication regimen complexity in patients with uncontrolled hypertension and\/or diabetes. J Am Pharm Assoc (2003). 2013;53(4):427\u201331.","journal-title":"J Am Pharm Assoc (2003)"},{"key":"3902_CR11","first-page":"37","volume":"6","author":"K Dalton","year":"2017","unstructured":"Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37.","journal-title":"Integr Pharm Res Pract"},{"issue":"10","key":"3902_CR12","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1111\/bcp.14041","volume":"85","author":"VM Sloeserwij","year":"2019","unstructured":"Sloeserwij VM, Hazen ACM, Zwart DLM, Leendertse AJ, Poldervaart JM, de Bont AA, et al. Effects of non-dispensing pharmacists integrated in general practice on medication-related hospitalisations. Br J Clin Pharmacol. 2019;85(10):2321\u201331.","journal-title":"Br J Clin Pharmacol"},{"key":"3902_CR13","doi-asserted-by":"crossref","unstructured":"Rodriguez de Bittner M, Chirikov VV, Breunig IM, Zaghab RW, Shaya FT. Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling. J Am Pharm Assoc (2003). 2017;57(1):102\u2013108.e4.","DOI":"10.1016\/j.japh.2016.08.010"},{"issue":"3","key":"3902_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/QMH.0000000000000304","volume":"30","author":"M Khammarnia","year":"2021","unstructured":"Khammarnia M, Ansari-Moghaddam AR, Setoodehzadeh F, Rezaei K, Clark CCT, Peyvand M. A systematic review and Meta-analysis of the Medical Error Rate in Iran: 2005\u20132019. Qual Manag Health Care. 2021;30(3):166\u201375.","journal-title":"Qual Manag Health Care"},{"key":"3902_CR15","doi-asserted-by":"crossref","unstructured":"Shahrami B, Forough AS, Najmeddin F, Hadidi E, Toomaj S, Javadi MR et al. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic. J Clin Pharm Ther. 2022.","DOI":"10.1111\/jcpt.13628"},{"issue":"1","key":"3902_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2369-12-35","volume":"12","author":"G Stemer","year":"2011","unstructured":"Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2011;12(1):35.","journal-title":"BMC Nephrol"},{"issue":"3","key":"3902_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11096-019-00816-4","volume":"41","author":"F Al Raiisi","year":"2019","unstructured":"Al Raiisi F, Stewart D, Fernandez-Llimos F, Salgado TM, Mohamed MF, Cunningham S. Clinical pharmacy practice in the care of chronic kidney Disease patients: a systematic review. Int J Clin Pharm. 2019;41(3):630\u201366.","journal-title":"Int J Clin Pharm"},{"key":"3902_CR18","unstructured":"Managing C. Kidney Disease With MTM."},{"key":"3902_CR19","unstructured":"Vaidya SR, Aeddula NR. Chronic renal failure. Sci Basis Urol Second Ed. 2021;257\u201364."},{"issue":"8","key":"3902_CR20","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1007\/s11606-020-06537-z","volume":"36","author":"A Silva-Almod\u00f3var","year":"2021","unstructured":"Silva-Almod\u00f3var A, Hackim E, Wolk H, Nahata MC. Potentially inappropriately prescribed medications among Medicare Medication Therapy Management Eligible Patients with chronic kidney disease: an observational analysis. J Gen Intern Med. 2021;36(8):2346\u201352.","journal-title":"J Gen Intern Med"},{"issue":"7","key":"3902_CR21","doi-asserted-by":"publisher","first-page":"A847","DOI":"10.1016\/j.jval.2016.08.496","volume":"19","author":"YH Khan","year":"2016","unstructured":"Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH. Progression and outcomes of Non-dialysis Dependent chronic kidney Disease patients. Value Heal. 2016;19(7):A847\u20138.","journal-title":"Value Heal"},{"issue":"11","key":"3902_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0187139","volume":"12","author":"SJ Moon","year":"2017","unstructured":"Moon SJ, Lee WY, Hwang JS, Hong YP, Morisky DE. Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS ONE. 2017;12(11):1\u201318.","journal-title":"PLoS ONE"},{"issue":"5","key":"3902_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive validity of Medication Adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348\u201354.","journal-title":"J Clin Hypertens"},{"key":"3902_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1611179","volume":"377","author":"DR Berlowitz","year":"2017","unstructured":"Berlowitz DR, Foy CG, Kazis LE, Bolin L, Lonroy LB, Fitzpatrick P, for the SPRINT Study Research Group, et al. Ipact of intensive blood pressure therapy on patient-reported outcomes:outcomes results from the SPRINT Study. N Engl J Med. 2017;377:733\u201344.","journal-title":"N Engl J Med"},{"key":"3902_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJMsa1616035","volume":"377","author":"AP Bress","year":"2017","unstructured":"Bress AP, Bellows BK, King J, Hess R, Beddhu S, Zhang Z, for the SPRINT Research Group and the SPRINT Economics and Health Related Quality of Life Subcommittee, et al. Cost-effectiveness of intensive versus standard blood pressure control. N Engl J Med. 2017;377:745\u201355.","journal-title":"N Engl J Med"},{"key":"3902_CR26","unstructured":"Johnson E, Bartman B, Briesacher B. Medication Therapy Management Interventions in Outpatient Settings Executive Summary. Agency Healthc Res Qual [Internet]. 2012;(90):1\u201324. Available from: www.effectivehealthcare."},{"key":"3902_CR27","unstructured":"NKF KDOQI clinical. practice guidelines | National Kidney Foundation."},{"issue":"6","key":"3902_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/ijpp\/riab033","volume":"29","author":"A Sch\u00fctze","year":"2021","unstructured":"Sch\u00fctze A, Hohmann C, Haubitz M, Radziwill R, Ben\u00f6hr P. Medicines optimization for patients with chronic kidney disease in the outpatient setting: the role of the clinical pharmacist. Int J Pharm Pract. 2021;29(6):587\u201397.","journal-title":"Int J Pharm Pract"},{"issue":"11","key":"3902_CR29","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.5005\/jp-journals-10071-23919","volume":"25","author":"M Aghili","year":"2021","unstructured":"Aghili M, Kasturirangan MN. Management of drug-drug interactions among critically ill patients with chronic kidney disease: impact of clinical pharmacist\u2019s interventions. Indian J Crit Care Med. 2021;25(11):1226\u201331.","journal-title":"Indian J Crit Care Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03902-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:07:48Z","timestamp":1734523668000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03902-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3902"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03902-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4625341\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Faculty of Pharmacy of Shahid Beheshti University of Medical Sciences approved this study with the ethics code IR.SBMU.PHARMACY.REC.1398.045. Informed consent to participate was obtained from all of the eligible patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"463"}}